Loading company…
Napo Therapeutics develops plant-based medicines for rare and serious conditions.
Napo Therapeutics develops plant-based pharmaceutical products and conducts clinical research for conditions including short bowel syndrome and congenital diarrheal disorders. It also offers early access programs for patients. Founded in 2021, it is based in Milan, Italy. In February 2023, it raised EUR 7 million in venture funding from Sprim Ventures and Jaguar Health, Inc.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in